Logo image of CCVI

CHURCHILL CAPITAL CORP VI-A (CCVI) Stock Fundamental Analysis

USA - NYSE:CCVI - US17143W1018 - Common Stock

10.485 USD
+0 (+0.05%)
Last: 12/1/2023, 8:04:00 PM
Fundamental Rating

1

CCVI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of CCVI have multiple concerns. CCVI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CCVI was profitable.
In the past year CCVI has reported a negative cash flow from operations.
CCVI Yearly Net Income VS EBIT VS OCF VS FCFCCVI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 10M 20M

1.2 Ratios

Industry RankSector Rank
ROA 3.66%
ROE 4.08%
ROIC N/A
ROA(3y)1.53%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCVI Yearly ROA, ROE, ROICCCVI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2 4

1.3 Margins

CCVI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CCVI Yearly Profit, Operating, Gross MarginsCCVI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CCVI remains at a similar level compared to 1 year ago.
CCVI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCVI Yearly Shares OutstandingCCVI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 20M 40M 60M
CCVI Yearly Total Debt VS Total AssetsCCVI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 8.43 indicates that CCVI is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that CCVI is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 8.43
ROIC/WACCN/A
WACCN/A
CCVI Yearly LT Debt VS Equity VS FCFCCVI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 100M 200M 300M 400M 500M

2.3 Liquidity

CCVI has a Current Ratio of 0.26. This is a bad value and indicates that CCVI is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.26 indicates that CCVI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
CCVI Yearly Current Assets VS Current LiabilitesCCVI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CCVI have decreased strongly by -58.70% in the last year.
EPS 1Y (TTM)-58.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 55.18, the valuation of CCVI can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 27.57, CCVI is valued quite expensively.
Industry RankSector Rank
PE 55.18
Fwd PE N/A
CCVI Price Earnings VS Forward Price EarningsCCVI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CCVI Per share dataCCVI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CCVI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHURCHILL CAPITAL CORP VI-A

NYSE:CCVI (12/1/2023, 8:04:00 PM)

10.485

+0 (+0.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.26%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap433.14M
Revenue(TTM)N/A
Net Income(TTM)10.55M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 55.18
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.68
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)0.19
EY1.81%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0
BVpS6.26
TBVpS6.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 4.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.53%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z 8.43
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.67%
OCF growth 3YN/A
OCF growth 5YN/A